Tag: CX
CX 2023: IN.PACT AV three-year subanalysis trial data show “durable” long-term...
The vascular access masterclass session on Tuesday saw a first-to-podium presentation by Andrew Holden (Auckland City Hospital, Auckland, New Zealand) in which he presented...
Endurant stent graft proves efficacious and durable in ENGAGE 10-year data
A first-to-podium presentation at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK) saw Hence Verhagen (Erasmus Medical Center, Rotterdam, The Netherlands)...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
Vascular News 97 – February 2023 US Edition
In this issue:
CX 2023 preview: Headline peripheral session to spotlight audience view on new BASIL-2 findings
Journal highlight: Individual patient data meta-analysis probes safety...
Vascular News 97 – February 2023 OUS Edition
In this issue:
CX 2023 preview: Headline peripheral session to spotlight audience view on new BASIL-2 findings
Journal highlight: Individual patient data meta-analysis probes...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...
CX 2022 highlights new data in the vascular world
Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...
CX Aortic Vienna showcases best abstracts
CX Aortic Vienna (8–11 September, virtual) hosted a “Best of CX and all abstracts” session on Wednesday, highlighting some of the more impactful and...
